Subscribe to the IQVIA Institute
Be among the first to hear about research and activities
| CARVIEW |
Select Language
HTTP/1.1 200 OK
Cache-Control: no-cache, no-store
Pragma: no-cache
Content-Type: text/html; charset=utf-8
Expires: -1
Server: Microsoft-IIS/10.0
Set-Cookie: shotgun#lang=en; path=/; secure; SameSite=None
Set-Cookie: shell#lang=en; path=/; secure; SameSite=None
Set-Cookie: ASP.NET_SessionId=jk1gkvepf3yofqldtgjjbpor; path=/; secure; HttpOnly; SameSite=None
Access-Control-Allow-Methods: GET, POST, PUT, DELETE, OPTIONS
Access-Control-Allow-Origin: https://quintiles.sharepoint.com
Access-Control-Allow-Headers: Content-Type, Authorization, LaunchPad-Client-Type
X-Frame-Options: DENY
X-XSS-Protection: 1; mode=block
Strict-Transport-Security: max-age=63072000; includeSubDomains; preload
Content-Security-Policy: default-src 'self' 'unsafe-inline' 'unsafe-eval'; script-src 'self' 'unsafe-inline' 'unsafe-eval' https://cdn.boomtrain.com https://c1.rfihub.net https://live.rezync.com https://assets.adobedtm.com https://bat.bing.com https://bat.bing-int.com https://kit.fontawesome.com players.brightcove.net vjs.zencdn.net https://www.buzzsprout.com https://static.zohocdn.com https://sdk.ceros.com https://labs.ceros.com https://trk.techtarget.com https://connect.facebook.net https://creative-services.ceros.com https://www.googleadservices.com https://connect.facebook.net https://eloquatracking.iqvia.com https://script.hotjar.com https://img03.en25.com https://static.hotjar.com https://snap.licdn.com https://edge.fullstory.com https://www.clickcease.com https://cdn.pagesense.io https://www.google-analytics.com https://googleads.g.doubleclick.net https://www.googletagmanager.com https://dev.visualwebsiteoptimizer.com https://unpkg.com https://cdn.jsdelivr.net https://cdnjs.cloudflare.com https://kit.fontawesome.com https://players.brightcove.net https://ajax.googleapis.com https://static.cloud.coveo.com https://tag.demandbase.com https://cookie-cdn.cookiepro.com https://www.google.com https://www.gstatic.com https://view.ceros.com; img-src 'self' blob: data: https://bat.bing.com https://s.gravatar.com https://www.google.pl https://www.linkedin.com players.brightcove.net *.boltdns.net *.akamaihd.net *.brightcove.com *.brightcovecdn.com https://i.ibb.co https://ad.doubleclick.net https://www.google.co.in https://www.google.com https://googleads.g.doubleclick.net https://www.googletagmanager.com https://attr.ml-api.io https://secure.adnxs.com https://www.google-analytics.com https://www.facebook.com https://attr.ml-api.ios https://secure.adnxs.com https://s.ml-attr.com https://eloquatracking.iqvia.com https://metrics.brightcove.com https://cf-images.us-east-1.prod.boltdns.net https://id.rlcdn.com https://cookie-cdn.cookiepro.com https://www.iqvia.com https://*.wp.com/cdn.auth0.com https://px.ads.linkedin.com https://segments.company-target.com; style-src 'self' 'unsafe-inline' https://use.fontawesome.com players.brightcove.net https://maxcdn.bootstrapcdn.com https://fonts.googleapis.com https://unpkg.com https://cdn.jsdelivr.net https://cdnjs.cloudflare.com; connect-src 'self' https://events.api.boomtrain.com https://people.api.boomtrain.com https://unpkg.com https://bat.bing.com https://bat.bing-int.com https://region1.analytics.google.com *.boltdns.net players.brightcove.net edge.api.brightcove.com *.akamaihd.net *.brightcovecdn.com https://region1.google-analytics.com https://metrics.hotjar.io https://stats.g.doubleclick.net https://analytics.google.com https://ibc-flow.techtarget.com https://vc.hotjar.io https://googleads.g.doubleclick.net https://px.ads.linkedin.com https://pagesense-collect.zoho.com https://edge.fullstory.com https://rs.fullstory.com https://www.google-analytics.com https://td.doubleclick.net https://www.google.com https://bcbolt446c5271-a.akamaihd.net https://house-fastly-signed-us-east-1-prod.brightcovecdn.com https://manifest.prod.boltdns.net https://ka-f.fontawesome.com https://edge.api.brightcove.com https://cookie-cdn.cookiepro.com https://api.company-target.com https://pagead2.googlesyndication.com; font-src 'self' 'unsafe-inline' https://kit.fontawesome.com players.brightcove.net https://use.fontawesome.com https://maxcdn.bootstrapcdn.com https://fonts.gstatic.com https://ka-f.fontawesome.com data:; worker-src 'self' 'unsafe-inline' blob:; media-src 'self' blob: *.brightcovecdn.com *.boltdns.net *.media.brightcove.com *.akamaihd.net *.cf.brightcove.com; frame-src 'self' https://20874701p.rfihub.com players.brightcove.net https://www.buzzsprout.com https://view.ceros.com https://11057559.fls.doubleclick.net https://www.facebook.com https://td.doubleclick.net https://s.company-target.com https://www.google.com https://view.ceros.com https://www.googletagmanager.com; upgrade-insecure-requests;
Date: Mon, 06 Oct 2025 07:15:32 GMT
Content-Length: 51022
Set-Cookie: BIGipServerwww.iqvia.com_http_prod_pool=!t+F6wFGdHYcy3CmgjLWxicALu0FP5g1bynbFNELcaGqi0m7dh3XV6JX9vKvK0ptXfyqfPSdbziuxdfw=; path=/; Httponly; Secure
LaunchPad-Client-Type: external
Vary: Accept-Encoding
Content-Encoding: gzip
Connection: Keep-Alive
The IQVIA Institute for Human Data Science - IQVIA
Explore IQVIA by region
As a global community, IQVIA continuously invests and commits to advancing human health.
Americas
Europe
Asia & Oceania
Middle East & Africa
Regional Thought Leadership
Explore IQVIA by region
As a global community, IQVIA continuously invests and commits to advancing human health.
Americas
Europe
Asia & Oceania
Middle East & Africa
Regional Thought Leadership
MAIN/Solutions
Solutions/
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases & Vaccines
- Oncology & Hematology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS
- Real World & Healthcare Data
- Health Data Apps & AI
- Analytics Research Accelerator
- Expert Ecosystem
- AI Patient & HCP Profiling- Commercial
- AI Patient & Provider Profiling- Med Affairs
- AI Patient & HCP Profiling- Healthcare
- Natural Language Processing
- Market Access Insights
- Direct-to-Patient Research
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSMAIN/About
About/
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI®
-
IQVIA AI Assistant
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Global Health
- Code of Conduct
- Sustainability
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Meet the IQVIA AI Assistant
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREMAIN/Careers
Careers/
IQVIA Careers
Featured Careers
Stay Connected
WE'RE HIRING
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESThe IQVIA Institute for Human Data Science
Evidence-based insights for healthcare
The IQVIA Institute for Human Data Science™ contributes to the advancement of human health globally through timely research, insightful analysis and scientific expertise applied to granular non-identified patient-level data.
Latest Reports
Download the latest Institute reports
Institute Report
Optimizing Care Delivery for Patients With Cancer
Integrating Patient Awareness of Evidence-Based Care, Engagement in Key Decision-Making Points, and Shared Decision‑making
Institute Report
Advancing Evidence-Based Academic Research 2025
Bibliography of Published Papers and Presentations Using IQVIA Information
Institute Report
Oncology Therapy Access in the Era of Personalized Medicine
Trends in regulatory approval and reimbursement for select countries in the Middle East and Africa
Institute Report
Key Access Pathways and Bottlenecks for Medicines in LMICs
Data Insights into Recently Launched and Established Medicines
Optimizing Care Delivery for Patients With Cancer
Advancing Evidence-Based Academic Research 2025
Oncology Therapy Access in the Era of Personalized Medicine
Trends in Drug Shortages and ANDA Approvals in the U.S.
The Global Use of Medicines Outlook Through 2029
Key Access Pathways and Bottlenecks for Medicines in LMICs
View all recent reports
Webinar
Strengthening Europe as a Global Center for Oncology Trials: Pre-ESMO Symposium 2025
Efforts to strengthen Europe as a global center for oncology clinical trials have been underway for some time, and multiple initiatives have been launched by stakeholders in recent years. At the same time, changes at the U.S. FDA and implementation of the EU Health Technology Assessment Regulation from January 2025 are bringing new considerations for sponsors deciding where to place their trial sites.
During this symposium, we will assess what progress has been achieved since the IQVIA Institute’s symposium held a year ago, examine the changes brought by the new U.S. administration, and discuss the impact of Joint Clinical Assessment requirements for all new oncology drugs submitted for registration by the EMA. We will also explore the increased use of trial sites in China and Australia.
Institute Report
Advancing Evidence-Based Academic Research 2025
Bibliography of Published Papers and Presentations Using IQVIA Information
Video Research Brief
Unlocking Biosimilar Potential: Learnings from an Osteoporosis Case Study of Complex Patient Pathways
Report reveals varied physician views on biosimilars, highlighting access gaps, low familiarity in some groups, and the need for education and policy to boost adoption, using osteoporosis as a case study.
Insight Brief
Pathways to Overcome Challenges to CAR T-cell Therapy Readiness
This webinar convened global experts to explore the evolving landscape of CAR T-cell therapy and assess health system readiness across countries. Panelists shared insights on policy gaps, patient access, and cross-sector solutions to accelerate equitable delivery. The session built on findings from the IQVIA Institute’s recent report and outlined key actions to strengthen CAR T-cell therapy implementation worldwide.
Video Research Brief
The Global Use of Medicines Outlook Through 2029
Hear from the report authors as they share key findings on global medicine use and rising spending, driven by innovative therapies and widening access. This report analyzes global trends and provides insights for stakeholders through 2029.
Video Research Brief
Designing Oncology Clinical Development Programs in the Era of the IRA
Watch our eminent panelists share their perspectives on the impact of the IRA on oncology drug development strategy, the implications for clinical development stakeholders, and approaches to mitigating unintended consequences for innovation at the IQVIA Institute’s Pre-ASCO Symposium 2025.
Explore the Latest
Our Thinking
Webinar
Pathways To Overcome Challenges to CAR T-Cell Therapy Health System Readiness
April 29, 2025
Video
2025 Indicators of Progress for the Life Sciences Sector
How will we know if the sector is advancing in 2025?
Blog
What Advances were Made in the Life Sciences Sector in 2024?
By:
Murray Aitken
A Look Back at 7 Indicators of Progress
Prev
Next
View all of the IQVIA Institute's Upcoming and On-Demand Events
Trending
Annual Reports on Latest Trends
The Global Use of Medicines
Learn about spending and usage of medicines in the past year and outlook to the future, globally and across specific therapy areas and countries.
Global Trends in R&D
Discover trends in drug approvals and launches, pipeline activity, and data on clinical trial activity.
The Use of Medicines in the U.S.
Examine the state of the U.S. health system, medicine usage, drug pricing, and costs for patients.
Global Oncology Trends
Explore research and development in oncology and the progress being made to improve representativeness of race and ethnicity in clinical trial populations.
You are about to exit for another IQVIA country or region specific website
Please be aware that the website you have requested is intended for the residents of particular country or region, as noted on that site.